Cargando…
Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445621/ https://www.ncbi.nlm.nih.gov/pubmed/28548101 http://dx.doi.org/10.1038/srep46833 |
_version_ | 1783238932031340544 |
---|---|
author | Song, Chengli Wang, Lina Xu, Qiang Wang, Kai Xie, Dan Yu, Zhe Jiang, Kui Liao, Lujian Yates, John R. Lee, Jiing-Dwan Yang, Qingkai |
author_facet | Song, Chengli Wang, Lina Xu, Qiang Wang, Kai Xie, Dan Yu, Zhe Jiang, Kui Liao, Lujian Yates, John R. Lee, Jiing-Dwan Yang, Qingkai |
author_sort | Song, Chengli |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5445621 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-54456212017-05-30 Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma Song, Chengli Wang, Lina Xu, Qiang Wang, Kai Xie, Dan Yu, Zhe Jiang, Kui Liao, Lujian Yates, John R. Lee, Jiing-Dwan Yang, Qingkai Sci Rep Corrigenda Nature Publishing Group 2017-05-26 /pmc/articles/PMC5445621/ /pubmed/28548101 http://dx.doi.org/10.1038/srep46833 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Corrigenda Song, Chengli Wang, Lina Xu, Qiang Wang, Kai Xie, Dan Yu, Zhe Jiang, Kui Liao, Lujian Yates, John R. Lee, Jiing-Dwan Yang, Qingkai Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma |
title | Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma |
title_full | Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma |
title_fullStr | Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma |
title_full_unstemmed | Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma |
title_short | Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma |
title_sort | corrigendum: targeting bmk1 impairs the drug resistance to combined inhibition of braf and mek1/2 in melanoma |
topic | Corrigenda |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445621/ https://www.ncbi.nlm.nih.gov/pubmed/28548101 http://dx.doi.org/10.1038/srep46833 |
work_keys_str_mv | AT songchengli corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma AT wanglina corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma AT xuqiang corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma AT wangkai corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma AT xiedan corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma AT yuzhe corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma AT jiangkui corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma AT liaolujian corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma AT yatesjohnr corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma AT leejiingdwan corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma AT yangqingkai corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma |